Is anti‐IL‐17 faster and anti‐IL‐23 better for psoriasis patients after adalimumab failure?

• Xiaojun Shi,
• Keke Li,
• Chen Li

Affiliations

Xiaojun Shi

Department of Rheumatology, Dongfang Hospital Beijing University of Chinese Medicine Beijing China

Keke Li

Department of Dermatology Hunan Children's Hospital Changsha Hunan China

Chen Li

Department of Rheumatology, Fangshan Hospital Beijing University of Chinese Medicine Beijing China